These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25204817)

  • 1. How can nanoparticles be used to overcome the challenges of glaucoma treatment?
    Venkatraman S; Wong T
    Nanomedicine (Lond); 2014 Jul; 9(9):1281-3. PubMed ID: 25204817
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers.
    Gan L; Wang J; Jiang M; Bartlett H; Ouyang D; Eperjesi F; Liu J; Gan Y
    Drug Discov Today; 2013 Mar; 18(5-6):290-7. PubMed ID: 23092895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in intraocular sustained-release drug delivery devices.
    Cao Y; Samy KE; Bernards DA; Desai TA
    Drug Discov Today; 2019 Aug; 24(8):1694-1700. PubMed ID: 31173915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study.
    Singh J; Chhabra G; Pathak K
    Drug Dev Ind Pharm; 2014 Sep; 40(9):1223-32. PubMed ID: 23837522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye.
    Vaneev A; Tikhomirova V; Chesnokova N; Popova E; Beznos O; Kost O; Klyachko N
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymeric hydrogels for novel contact lens-based ophthalmic drug delivery systems: a review.
    Xinming L; Yingde C; Lloyd AW; Mikhalovsky SV; Sandeman SR; Howel CA; Liewen L
    Cont Lens Anterior Eye; 2008 Apr; 31(2):57-64. PubMed ID: 17962066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular delivery of macromolecules.
    Kim YC; Chiang B; Wu X; Prausnitz MR
    J Control Release; 2014 Sep; 190():172-81. PubMed ID: 24998941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in preservative-free glaucoma drops].
    Stefan C; Pop A; Cojocaru I
    Oftalmologia; 2011; 55(2):3-6. PubMed ID: 21888063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Local ocular drugs in France in 1984].
    Faure MH
    Bull Soc Ophtalmol Fr; 1985 Mar; 85(3):393-8. PubMed ID: 4092339
    [No Abstract]   [Full Text] [Related]  

  • 10. Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity.
    Pignatello R; Carbone C; Puglia C; Offerta A; Bonina FP; Puglisi G
    Ther Deliv; 2015; 6(11):1297-318. PubMed ID: 26608630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug delivery systems for topical ophthalmic medication.
    Halberg GP; Kelly SE; Morrone M
    Ann Ophthalmol; 1975 Sep; 7(9):1199-1204, 1207-9. PubMed ID: 1163927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advance of the application of nano-controlled release system in ophthalmic drug delivery.
    Wang X; Wang S; Zhang Y
    Drug Deliv; 2016 Oct; 23(8):2897-2901. PubMed ID: 26635087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular drug delivery-eye on innovation.
    Rupenthal ID; O'Rourke M
    Drug Deliv Transl Res; 2016 Dec; 6(6):631-633. PubMed ID: 27766597
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug delivery to the back of the eye.
    Kompella UB
    Arch Soc Esp Oftalmol; 2007 Nov; 82(11):667-8; 669-70. PubMed ID: 17979032
    [No Abstract]   [Full Text] [Related]  

  • 15. Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide.
    Verma P; Gupta RN; Jha AK; Pandey R
    Drug Deliv; 2013; 20(7):269-76. PubMed ID: 24044644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New Direction in Ophthalmic Development: Nanoparticle Drug Delivery Systems.
    Andonova VY
    Curr Pharm Des; 2016; 22(41):6313-6329. PubMed ID: 27526789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained drug release by contact lenses for glaucoma treatment-a review.
    Carvalho IM; Marques CS; Oliveira RS; Coelho PB; Costa PC; Ferreira DC
    J Control Release; 2015 Mar; 202():76-82. PubMed ID: 25617723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temperature sensitive contact lenses for triggered ophthalmic drug delivery.
    Jung HJ; Chauhan A
    Biomaterials; 2012 Mar; 33(7):2289-300. PubMed ID: 22182750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment effectiveness in open-angle glaucoma using aqueous and prolonged-action armin solutions].
    Khasanova NKh; Valiullina FG; Krasnov LE
    Vestn Oftalmol; 1980; (3):18-20. PubMed ID: 7404931
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolonged release medication in the treatment of eye disease.
    Lerman S
    Isr J Med Sci; 1972; 8(8):1402-5. PubMed ID: 4647794
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.